Citadel Advisors’s Humankind US Stock ETF HKND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-35,153
Closed -$949K 14696
2023
Q3
$949K Buy
35,153
+1,917
+6% +$54K ﹤0.01% 6662
2023
Q2
$935K Buy
+33,236
New +$910K ﹤0.01% 6607
2022
Q4
Sell
-44,716
Closed -$1.07M 15103
2022
Q3
$1.07M Buy
44,716
+12,781
+40% +$338K ﹤0.01% 6851
2022
Q2
$821K Sell
31,935
-1,965
-6% -$54K ﹤0.01% 7482
2022
Q1
$998K Buy
33,900
+25,500
+304% +$734K ﹤0.01% 7695
2021
Q4
$250K Buy
+8,400
New +$241K ﹤0.01% 11354

Other funds holding HKND

Citadel Advisors's HKND Position: Q4 2023 in Review

Citadel Advisors sold out of Humankind US Stock ETF (HKND) in Q4 2023, closing a stake of 35,153 shares — an estimated $949K sold.

Citadel Advisors first reported a position in HKND in Q4 2021 and held it in 6 quarters. The position peaked at $1.07M in Q3 2022. 4 funds tracked by Wall St. Rank hold HKND as of Q4 2023.

  • Citadel Advisors reported no remaining Humankind US Stock ETF position as of Q4 2023 after selling out during the quarter.
  • Citadel Advisors sold 35,153 Humankind US Stock ETF shares in Q4 2023, an estimated $949K.
  • Citadel Advisors first reported a position in Humankind US Stock ETF in Q4 2021 and held it in 6 quarters.
  • Citadel Advisors's Humankind US Stock ETF position peaked at $1.07M in Q3 2022.
  • 4 funds tracked by Wall St. Rank held Humankind US Stock ETF as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.